| 000 | 01697 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518053736.0 | ||
| 264 | 0 | _c20200403 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a2211-0356 | ||
| 024 | 7 |
_a10.1016/j.msard.2019.08.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorakova, D | |
| 245 | 0 | 0 |
_aInitiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS. _h[electronic resource] |
| 260 |
_bMultiple sclerosis and related disorders _cOct 2019 |
||
| 300 |
_a196-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCzech Republic |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aRockova, P | |
| 700 | 1 | _aJircikova, J | |
| 700 | 1 | _aDolezal, T | |
| 700 | 1 | _aVachova, M | |
| 700 | 1 | _aHradilek, P | |
| 700 | 1 | _aValis, M | |
| 700 | 1 | _aSucha, J | |
| 700 | 1 | _aMartinkova, A | |
| 700 | 1 | _aAmpapa, R | |
| 700 | 1 | _aGrunermelova, M | |
| 700 | 1 | _aStetkarova, I | |
| 700 | 1 | _aStourac, P | |
| 700 | 1 | _aMares, J | |
| 700 | 1 | _aDufek, M | |
| 700 | 1 | _aKmetova, E | |
| 700 | 1 | _aAdamkova, J | |
| 700 | 1 | _aHrnciarova, T | |
| 773 | 0 |
_tMultiple sclerosis and related disorders _gvol. 35 _gp. 196-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.msard.2019.08.003 _zAvailable from publisher's website |
| 999 |
_c29993676 _d29993676 |
||